May 1, 2019 | Drugs, EAS in Action, EASeNews
Senior Director for Pharmaceutical and Medical Device Consulting Services, Bryan Coleman, wrote a blog for the ISPE’s iSpeak on opportunities ahead for the pharma industry as the Agency works to streamline processes for improved innovations.
May 1, 2019 | Drug and Device Corner, Drugs, Medical Devices
It has come to EAS’s attention that there is significant confusion regarding the exemption of Class 1 Medical Device products to comply with the 21 CFR 801.20 requirement for the label of a medical device to bear a unique device identifier. Per 21 CFR 801.30 A class I...
May 1, 2019 | Drugs, EASeNews, Extra Article
FDA issued a Final Rule, effective April 13, 2019, which aims to ensure the safety and effectiveness of OTC hand sanitizers, formally known as topical consumer antiseptic rub products. These products are intended for use without water and marketed under the FDA’s OTC...
Apr 1, 2019 | Drug and Device Corner, Drugs, Medical Devices
Implementation of reorganization to begin for CDRH In order to create a smart and quick-moving infrastructure that can adapt to the needs of future organizational, regulatory and scientific requirements, the Center for Devices and Radiological Health (CDRH) is...
Mar 1, 2019 | Drug and Device Corner, Drugs, Medical Devices
Sunscreen Innovation Act to Enhance Product Safety Requirements On February 21, 2019 FDA issued a proposed rule that would update regulatory requirements for most sunscreen products in the United States. Aimed at bringing nonprescription, over-the-counter (OTC)...
Feb 1, 2019 | Drug and Device Corner, Drugs, Medical Devices
With the Federal Register (FR) publication unavailable, the FDA has published Safety and Performance-Based Pathway on the Guidance Document webpage. Full details will be available in the Federal Register once that site is again functioning. The existing Docket Number...